SEC Form 4 · accession 0001127602-17-023518
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jul 10, 2017
Accepted (ET)
Jul 12, 2017 · 7:13 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2017 | S | 100 | $99.185 | D | 342,298 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $99.19 | D | 342,098 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.195 | D | 341,998 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $99.20 | D | 341,798 | D | |
| Common Stock | Jul 10, 2017 | S | 5 | $99.205 | D | 341,793 | D | |
| Common Stock | Jul 10, 2017 | S | 912 | $99.21 | D | 340,881 | D | |
| Common Stock | Jul 10, 2017 | S | 1 | $99.215 | D | 340,880 | D | |
| Common Stock | Jul 10, 2017 | S | 613 | $99.22 | D | 340,267 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $99.23 | D | 340,067 | D | |
| Common Stock | Jul 10, 2017 | S | 200 | $99.25 | D | 339,867 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.255 | D | 339,767 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.26 | D | 339,667 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.27 | D | 339,367 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.28 | D | 339,267 | D | |
| Common Stock | Jul 10, 2017 | S | 99 | $99.29 | D | 339,168 | D | |
| Common Stock | Jul 10, 2017 | S | 249 | $99.30 | D | 338,919 | D | |
| Common Stock | Jul 10, 2017 | S | 40 | $99.315 | D | 338,879 | D | |
| Common Stock | Jul 10, 2017 | S | 700 | $99.32 | D | 338,179 | D | |
| Common Stock | Jul 10, 2017 | S | 101 | $99.33 | D | 338,078 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.37 | D | 337,778 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.395 | D | 337,678 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.40 | D | 337,578 | D | |
| Common Stock | Jul 10, 2017 | S | 300 | $99.41 | D | 337,278 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.42 | D | 337,178 | D | |
| Common Stock | Jul 10, 2017 | S | 100 | $99.54 | D | 337,078 | D | |
| Common Stock | Jul 10, 2017 | S | 400 | $99.62 | D | 336,678 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.